Drugs for treatment of very high blood pressure during pregnancy. (Q30879667)

27 June 2017

0 references

1 reference

title

Drugs for treatment of very high blood pressure during pregnancy. (English)

1 reference

27 June 2017

L Duley

1

0 references

author name string

D J Henderson-Smart

series ordinal

2

1 reference

27 June 2017

publication date

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

27 June 2017

published in

1 reference

27 June 2017

issue

4

1 reference

27 June 2017

page(s)

CD001449

1 reference

Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Oral nifedipine therapy in the management of severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

An open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Long-term treatment with nicardipine for severe pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Sublingual isosorbide dinitrate in the acute control of hypertension in patients with severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

A comparison of hypotensive drugs in patients with hypertensive disorders in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

The optimal dosage of ketanserin for patients with severe hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Management of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

Pre-eclampsia: more than pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001449

10.1002/14651858.CD001449

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference